Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.
about
Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART eraHIV and aging: emerging research issuesImmunologic Biomarkers, Morbidity, and Mortality in Treated HIV InfectionImpact of illicit opioid use on T cell subsets among HIV-infected adults.Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infectionImpact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging.Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohortActivated platelet-T-cell conjugates in peripheral blood of patients with HIV infection: coupling coagulation/inflammation and T cellsCooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell CountsRole of immune activation in progression to AIDS.Normal T-cell activation in elite controllers with preserved CD4+ T-cell countsBrief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART.IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework.CD57 in human natural killer cells and T-lymphocytes.Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV.Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls.The investigation of CD4+T-cell functions in primary HIV infection with antiretroviral therapy.Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8+ T Cell Exhaustion Marker Expression.Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment.Immunologic profiles distinguish aviremic HIV-infected adults.Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection.Soluble CD163 and Clinical Outcomes in Treated HIV Infection: Insights Into Mechanisms.Cost-Effectiveness of Peer- Versus Venue-Based Approaches for Detecting Undiagnosed HIV Among Heterosexuals in High-Risk New York City Neighborhoods.Immunophenotype and Function of CD38-Expressing CD4+ and CD8+ T Cells in HIV-Infected Patients Undergoing Suppressive Combination Antiretroviral Therapy
P2860
Q26768147-DD50806D-8885-4BAC-AB82-0262C36DE6FCQ27016011-8446F354-885A-4351-B681-F556387B9906Q30245379-5AE4CB86-0D05-4C26-98B3-CE742D954808Q33637866-C479D309-1B37-4384-8561-95B5D4DA363FQ34315572-15310DAA-A853-49C5-B9F8-FED8E88F25E7Q34396067-45E01293-7A3E-4852-B03C-1CFB1ACD8F91Q35107330-65DF811B-A58B-4134-9759-2D95AC8E1555Q35493901-4667F2B8-AC3A-4C6A-8CF2-1A1893E030EBQ35853807-E6DEFBC1-7D44-4C88-A51C-FFE069AA51EBQ35861240-54E589C7-4270-4FC2-99E1-7372A431946FQ36185688-F29343B8-6F4C-4195-B315-083100D0F83CQ36402470-A4AF6BA4-05E4-4D68-A6F7-7F61542DD7A1Q36571165-FBF2335D-7780-4396-AFF0-24221B195F1CQ36638690-74226A43-7289-45BD-AA57-CFC96FC7FEA9Q36905563-60E85492-AFB1-4D70-A3AA-F4536DD360D0Q37042241-C0B1EF8B-22DA-45BF-832B-664AAD996914Q38368637-270066FC-1243-4F84-8BD0-4AD49C11F206Q38724544-41F2A671-19A2-43C5-832B-98921371BA9CQ38741619-9C440E3D-C75B-47DF-B922-3AA2538F18CBQ40094624-6BF196F4-918A-45F5-8F1A-86AC855F6C44Q40125887-8FD00699-EB96-4CFC-B1ED-E20B9F45D12FQ40277312-1C63A8BE-2E04-43FA-9A2A-CF7E317F2194Q40549489-36130240-3856-4FBD-920B-D11648F7F2C0Q40716958-19018854-4068-4B38-8AF2-F423C86C2B76Q40800858-EE6B3A77-0573-46A9-90A2-7E955F0B1784Q41609336-50E7D1E0-BEF0-406A-BBF6-031A1D9C2DE5Q42201478-5BA28F72-6DC8-40A3-8F34-AED23C69628BQ46136379-8DE676DC-663F-49A6-B64B-AA8142F16D49Q47600979-25DFCB78-E555-4FD9-8043-22AB97390E41Q57203784-4609D97F-5BAE-4841-BBE0-510A74324EBE
P2860
Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Low proportions of CD28- CD8+ ...... lity in treated HIV infection.
@ast
Low proportions of CD28- CD8+ ...... lity in treated HIV infection.
@en
type
label
Low proportions of CD28- CD8+ ...... lity in treated HIV infection.
@ast
Low proportions of CD28- CD8+ ...... lity in treated HIV infection.
@en
prefLabel
Low proportions of CD28- CD8+ ...... lity in treated HIV infection.
@ast
Low proportions of CD28- CD8+ ...... lity in treated HIV infection.
@en
P2093
P2860
P356
P1476
Low proportions of CD28- CD8+ ...... lity in treated HIV infection.
@en
P2093
Curtis L Meinert
Elizabeth Sinclair
Jeffrey N Martin
Joseph M McCune
Lorrie Epling
Mark Van Natta
Michael M Lederman
Peter W Hunt
Sulggi A Lee
Vivek Jain
P2860
P304
P356
10.1093/INFDIS/JIU109
P407
P577
2014-02-28T00:00:00Z